OpenVSafe by OpenVAERS
Search V-safe

VCF-30071-76503

4 vaccinations 7 coded responses 25 check-ins 7 free-text entries 3 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
234 / VA
Registered
2021-03-26
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-24
    Dose 1 — Moderna
  2. 2021-03-26
    Registered in v-safe
  3. 2021-03-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache
    Adult check-in
  4. 2021-03-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-03-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Diarrhea
    Adult check-in
  6. 2021-03-31
    Health check-in — day 7, dose 1
    Feeling: Good · Diarrhea
    Adult check-in
  7. 2021-04-07
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-04-14
    Survey response — day 21, dose 1
    MedDRA: Pityriasis rosea — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Pityriasis Rosea - on opposite arm of vaccination
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-04-14
    Report sent to call center — day 21, dose 1
    Get care from a doctor or other healthcare professional
    1 call case(s)
  10. 2021-04-21
    Dose 2 — Moderna
  11. 2021-04-21
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-04-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  13. 2021-04-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness · Be unable to work
    Adult check-in
  14. 2021-04-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches
    Adult check-in
  15. 2021-04-25
    Survey response — days 1–6 daily, dose 2
    MedDRA: Pityriasis rosea — Feeling: Good · Site: Pain, Redness
    Free text: pityriasis rosea - has continued after first shot
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Rash, not including the immediate area around the injection site
    Adult check-in
  17. 2021-04-27
    Survey response — days 1–6 daily, dose 2
    MedDRA: Pityriasis rosea — Feeling: Good · Rash, not including the immediate area around the injection site
    Free text: pityriasis rosea - not resolved yet
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-04-30
    Survey response — day 7, dose 2
    MedDRA: Pityriasis rosea — Feeling: Good
    Free text: pityriasis rosea
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-05-08
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-05-12
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-19
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-28
    Survey response — day 35, dose 2
    MedDRA: Cough, Upper-airway cough syndrome — Feeling: Fair
    Free text: Cough, post nasal drip
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-06-04
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-07-21
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-10-20
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-11-20
    Dose 3 — Moderna
  27. 2022-02-19
  28. 2022-05-21
    Survey response — 6 months, dose 3
    MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Covid-19- April 28th
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-05-21
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  30. 2022-05-23
    Call successful
    Participant prefers to complete VAERS report online
  31. 2022-05-23
    Call successful
    Participant prefers to complete VAERS report online
  32. 2022-09-26
    Dose 4 — Moderna
    Co-administered: Flu
  33. 2022-11-20
    Survey response — 12 months, dose 3
    MedDRA: COVID-19, Delivery — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Developed Gestational Diabetes during pregnancy, immediately following covid diagnosis in April. I gave birth in August.
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-11-20
    Report sent to call center — 12 months, dose 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  35. 2022-11-21
  36. 2022-12-28
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  37. 2023-03-27
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-24Moderna
22021-04-21Moderna
32021-11-20Moderna No
42022-09-26Moderna Flu

Call center

ReportedOutcomeVAERS-related outcome
2021-04-14 Successful
2022-05-23
Participant prefers to complete VAERS report online
2022-05-21 Successful
2022-05-23
Participant prefers to complete VAERS report online
2022-11-20 Unsuccessful

Free text

Release 7 — day 21, dose 1

2021-04-14

Symptoms: Pityriasis Rosea - on opposite arm of vaccination

Release 7 — days 1–6 daily, dose 2

2021-04-25

Systemic reaction (other): pityriasis rosea - has continued after first shot

Release 8 — days 1–6 daily, dose 2

2021-04-27

Systemic reaction (other): pityriasis rosea - not resolved yet

Release 8 — day 7, dose 2

2021-04-30

Systemic reaction (other): pityriasis rosea

Release 8 — day 35, dose 2

2021-05-28

Symptoms: Cough, post nasal drip

Release 11 — 6 months, dose 3

2022-05-21

Symptoms: Covid-19- April 28th

Release 12 — 12 months, dose 3

2022-11-20

Symptoms: Developed Gestational Diabetes during pregnancy, immediately following covid diagnosis in April. I gave birth in August.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough ✓ ✓ ✓
SDCOVID-19 · · ✓
SDDelivery · · ✓
SDPityriasis rosea ✓ ✓ ✓
SDUpper-airway cough syndrome ✓ ✓ ✓
SROPityriasis rosea ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release